Samlyn Capital’s Allergan Inc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CA
ECM
HFS
AIM
Samlyn Capital's AGN Position: Q1 2015 in Review
Samlyn Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 675,186 shares — an estimated $144M sold.
Samlyn Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $193M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.
- Samlyn Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
- Samlyn Capital sold 675,186 Allergan Inc shares in Q1 2015, an estimated $144M.
- Samlyn Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
- Samlyn Capital's Allergan Inc position peaked at $193M in Q3 2014.
- 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.
Based on Samlyn Capital's 13F filing for Q1 2015, filed 15 May 2015.